Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model

Circulation

Volumn 97, Issue 7, 1998, Pages 633-636

  Muhlestein, Joseph B ^a,b   Anderson, Jeffrey L ^a   Hammond, Elizabeth H ^a   Zhao, Liping ^a   Trehan, Sanjeev ^a   Schwobe, Eric P ^a   Carlquist, John F ^a  

^a UNIVERSITY OF UTAH   (United States)

^b LDS HOSPITAL   (United States)

Author keywords

Atherosclerosis; Azithromycin; Chlamydia pneumoniae

Indexed keywords

AZITHROMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0032562148     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.7.633     Document Type: Article

References (14)

1. Grayston JT, Campbell LA, Kuo C-C, Mordhorst CH, Saikku P, Thom DH, Wang SP. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis. 1990;61:618-625.
2. Saikku P, Leinonen M, Tenkanen L, Linnanmaki E, Ekman MR, Manninen V, Manttari M, Frick MH, Huttunen JK. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann Intern Med. 1992;116:273-278.
3. Linnanmaki E, Leinonen M, Mattila K, Nieminen MS, Valtonen V, Saikku P. Chlamydia pneumoniae specific circulating immune complexes in patients with chronic coronary heart disease. Circulation. 1993;87:1130-1134.
4. Thom DH, Grayston JT, Siscovick DS, Wang S-P, Weiss NS, Daling JR, Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary heart disease. JAMA. 1992;268:68-72.
5. Kuo CC, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis. 1993;167:841-849.
6. Muhlestein JB, Hammond EH, Carlquist JF, Radicke E, Thomson MJ, Karagounis LA, Woods ML, Anderson JL. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol. 1996;27:1555-1561.
7. Ramirez JA. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis: the Chlamydia pneumoniae/Atherrosclerosis Study Group. Ann Intern Med. 1996;125:979-982.
8. Grayston JT, Kuo CC, Coulson AS, Campbell LA, Lawrence RD, Lee MJ, Strandness ED, Wang SP. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation. 1995;92:3397-3400.
9. Kuo C-C, Gown AM, Bendit EP, Grayston JT. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain, Anenoscler Thromb. 1993;13:1501-1504.
10. Moazed TC, Kuo C, Patton DL, Grayston JT, Campbell LA. Experimental rabbit models of Chlamydia pneumoniae infection. Am J Pathol. 1996;148:667-676.
11. Fong IW, Chiu B, Viira E, Fong MW, Jang D, Mahony J. Rabbit model for Chlamydia pneumoniae infection. J Clin Microbiol. 1997;35:48-52.
12. Kuo C-C, Grayston JT. A sensitive cell line, HL cells, for isolation and propagation of Chlamydia pneumoniae strain TWAR. J Infect Dis. 1990;16:755-758.
13. Mayer J, Woods ML, Vavrin Z, Hibbs JB. Gamma interferon-induced nitrci oxide production reduces chlamydial trachomatis infectivity in McCoy cells. Infect Immun. 1993;61:491-497.
14. Hammond EH, Muhlestein JB, Carlquist JF, Anderson JL. High incidence of Chlamydia pneumoniae in atherosclerosis of coronary arteries with both genus and species specific antisera. J Am Coll Cardiol. In press.